IJR News — today's news from every side
+18 Priya Raman A 35B valuation looks steep with those losses, but Nvidia backing could still pull in plenty of buyers.
+4 United Therapeutics and Denali Outline Pipeline Shifts at Morgan Stanley Conference x/sanfilippo-syndrome — Sep 14, 2026 Biotech firms Crescent Biopharma, Denali Therapeutics, Kyverna Therapeutics, and United Therapeutics outlined forthcoming data, new indications, and expansive commercial strategies at the Morgan Stanley Global Healthcare Conference, signaling a push into pulmonary fibrosis, CNS, and other large patient populations. Denali highlighted its Avlayah Transport Vehicle platform and CNS programs, while United Therapeutics outlined a four‑product strategy for IPF/PPF and planned NDA activities, underscoring continued innovation and manufacturing expansion across the sector. +5 Nicole Hardy Shifting focus to larger populations like pulmonary fibrosis makes sense for growth but competition will be fierce.+4 Dana Whitfield Reaching 17 billion by 2040 depends on hitting those production numbers, which Tesla has struggled with before.
OpenAI launches ChatGPT for Financial Services aimed at Wall Street tasks x/openai — Sep 10, 2026 OpenAI has rolled out ChatGPT for Financial Services, a tailored enterprise product powered by GPT-6 Astra that combines its AI with data from vendors like LSEG, PitchBook, and Daloopa, developed with Morgan Stanley and Evercore as design partners to aid analysts, researchers, and presentation work for Wall Street. The offering emphasizes governance and compliance—role-based access, encryption, and exportable logs—while enabling firms to integrate their existing data subscriptions and extend coverage across multiple sources to improve retrieval, citation, and client-material generation. +18 Priya Raman This integration with LSEG and PitchBook data could finally cut down the time analysts spend hunting across separate platforms.Wella files for NYSE IPO after swinging back to profit x/kohlberg-kravis-roberts — Aug 31, 2026 Wella Company, owner of brands such as Wella Professionals, OPI, Clairol and ghd, filed for a U.S. IPO to list on the New York Stock Exchange under the ticker WELA, with Goldman Sachs, BofA Securities, KKR, and J.P. Morgan among the underwriters. The move comes amid sustained revenue growth and profitability improvements, backed by KKR’s majority stake and a global footprint in more than 100 countries. +4 Anthropic nears $15 billion credit facility ahead of possible IPO x/anthropic-principle — Sep 3, 2026 Anthropic is close to securing a $15 billion revolving credit facility ahead of an anticipated IPO, led by Morgan Stanley with Goldman Sachs, JPMorgan Chase and Citigroup involved, and a broad roster of banks including Barclays, Wells Fargo, Bank of America, Deutsche Bank, RBC, and UBS. The massive line serves as a liquidity backstop to support operations and financing needs during the IPO process, potentially shaping the deal structure and market expectations for Anthropic’s public offering. +8 Dana Whitfield Feels like the credit facility is designed to make the IPO look stronger than it actually is on day one.+2 Nicole Hardy Interesting to see smaller names like DC Infotech and Awfis lined up right alongside Infosys, gives a sense of how packed the September calendar already is.Vor Bio to Join Wells Fargo, Citi and Other September Conferences x/wells-fargo — Aug 31, 2026 Biotech companies Conexeu Sciences, Vor Bio, Cabaletta Bio, and Jade Biosciences announced plans to participate in a string of September–October 2026 investor conferences, including management presentations, one-on-one meetings, and webcasted fireside chats across major events such as Wells Fargo, Citi, Morgan Stanley, Cantor, and others. The companies emphasize investor engagement and webcast availability as they push forward their autoimmune disease programs and tissue-restoration platforms. +6
